We compared the immunoexpression of 5 myoepithelial cell (MEC) markers (asmooth-muscle actin, calponin, h-caldesmon, vimentin, and S-100-protein) using 16 pleomorphic adenomas (PA), 15 adenoid cystic carcinomas (ACC), and 3 epithelialmyoepithelial carcinomas (EMC) of salivary glands. The cx-smooth-muscle actin was useful for identification of MECs, especially in cribriform and tubular ACC, followed by EMC. Calponin was similar to ct-smooth-muscle actin, except for polygonal and plasmacytoid cells of PA and for solid ACC, which showed a-smooth-muscle actin negative and calponin positive. H-caldesmon was negative. Vimentin immunostained all MEC types, and was negative in luminal cells. S-100 protein was expressed both in the nuclei and cytoplasm of MECs and luminal cells, especially in PA. The best way to identify MEC is using a-smooth-muscle actin or calponin, plus vimentin, since in tumors MECs are hardly ever fully differentiated.
1. Hara K, Ito M, Takeuchi J, lijima S, Endo T, Hidaka H. Distribution of S-lOOb protein in normal salivary glands and salivary gland tumors. Virchows Arch Pathol Anat40:237-249, 1983
2.
2. Zarbo RJ, Regezi JA, Batsakis JG. S-100 protein in salivary gland tumors: An immunohistochemical study of 129 cases. Head Neck Surg8:268-275, 1986
3.
3. Mori M, Tsukitani K, Ninomiya T, Okada Y. Various expression of modified myoepithelial cells in salivary pleomorphic adenoma. Immunohistochemical study. Pathol Res Pract182:632-646, 1987
4.
4. Azumi N, Battifora H. The cellular composition of adenoid cystic carcinoma. An immunohistochemical study. Cancer60:1589-1598, 1987
5.
5. Gugliotta P, Sapino A, Macri L, Skalli 0, Gabbiani G, Bussolati G. Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody. J Histochem Cytochem36:659-663, 1988
6.
6. Chen J-C, Gnepp DR, Bedrossian CWM. Adenoid cystic carcinoma of the salivary glands: An immunohistochemical analysis. Oral Surg Oral Med Oral Pathol65:316-326, 1988
7.
7. Hirano T, Gluckman JL, De Vries EJ. The expression of a vascular smooth-muscle actin in salivary gland tumors. Arch Otolaryngol Head Neck Surg116:692-696, 1990
8.
8. Jones H, Moshtael F, Simpson RHW. Immunoreactivity of a-smooth muscle actin in salivary gland tumours: A comparison with S100 protein. J Clin Pathol45:938-940, 1992
9.
9. Araujo VC, Carvalho YR, Araujo NS. Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study. Oral Surg Oral Med Oral Pathol77:387-391, 1994
10.
10. Erlandson RA, Cardon-Cardo C, Higgins PJ. Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol8:803-820, 1984
11.
11. Kahn HJ, Baumal R, Marks A, Dardick I, Van Nostrand AWP. Myoepithelial cells in salivary gland tumors. An immunohistochemical study. Arch Pathol Lab Med109:190-195, 1985
12.
12. Morinaga S, Nakajima T, Shimosato Y. Normal and neoplastic myoepithelial cells in salivary glands: An immunohistochemical study. Hum Pathol18:1218-1226, 1987
13.
13. Burns BF, Dardick I, Parks WR. Intermediate filament expression in normal parotid glands and pleomorphic adenomas. Virchows Archiv A Pathol Anat413:103-112, 1988
14.
14. Yamada K, Shinohara H, Takai Y, Mori M. Monoclonal antibody-detected vimentin distribution in pleomorphic adenomas of salivary glands. J Oral Pathol17:348-353, 1988
15.
15. Chomette G, Auriol M, Vaillant JM, Kasai T, Okada Y, Mori M. Heterogeneity and co-expression of intermediate filament proteins in adenoid cystic carcinoma of salivary glands. Pathol Biol39:110-116, 1991
16.
16. Araujo VC, Araujo NS. Vimentin as a marker of myoepithelial cells in salivary gland tumors. Eur Arch Otorhinolaryngol247:252-255, 1990
17.
17. Araujo VC, Sousa SOM, Carvalho YR, Araujo NS. Application of immunohistochemistry to the diagnosis of salivary gland tumors. AIMM8:195-202, 2000
18.
18. Araujo VC, Sousa S, Jaeger M, Jaeger R, Loyola A, Crivelini M, Araujo N. Characterization of cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol35:164-172, 1999
19.
19. Winder SJ, Sutherland C, Walsh MP. Biochemical and functional characterization of smooth muscle calponin. Adv Experiment Med Biol304:37-51, 1991
21. El-Mezgueldi M. Calponin. Int J Biochem Cell Biol28:1185-1189, 1996
22.
22. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery IP, Koteliansky VE. Expression of smooth musclespecific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA90:999-1003, 1993
23.
23. Savera AT, Gown AM, Zarbo RJ. Immunolocalization of three novel smooth muscle specific proteins in salivary gland pleomorphic adenoma: Assessment of the morphogenetic role of myoepithelium. Mod Pathol10:1093-1100, 1997
24.
24. Nagao T, Sugano I, Ishida Y, Tajima Y, Matsuzaki 0, Konno A, Kondo Y, Nagao K. Salivary gland malignant myoepithelioma. A clinicopathologic and immunohistochemical study of ten cases. Cancer83:1292-1299, 1998
25.
25. Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med123:801-806, 1999
26.
26. Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary gland: A clinic-pathologic study of 25 patients. Am J Surg Pathol24:761-774, 2000
27.
27. Foschini MP, Scarpellini F, Gown AM, Eusebi V. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol8:29-37, 2000
28.
28. Lam RMT. An electron microscopic histochemical study of the histogenesis of major salivary gland pleomorphic adenoma. Ultrastruct Pathol8:207-223, 1985
29.
29. Raitz R, Martins MD, Arauijo, VC. A study of the extracellular matrix in salivary gland tumors. J Oral Pathol Med32:290-296, 2003
30.
30. Dardick I, Van Nostrand AWP, Jeans MTD. Pleomorphic adenoma I: Ultrastructural organization of “ epithelial” regions. Hum Pathol14:780-797, 1983
31.
31. Frid MG, Shekhonin BV, Koteliansky VE, Glukhova MA. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin. Develop Biol53:185-193, 1992
32.
32. Deugnier MA, Moiseyeva EP, Thiery JP, Glukhova M. Myoepithelial cell differentiation in the developing mammary gland: Progressive aquisition of smooth muscle phenotype. Dev Dyn204:107-117, 1995
33.
33. Small JV, Gimona M. The cytoskeleton of the vertebrate smooth muscle cell. Acta Phisiol Scand164:341-348, 1998
34.
34. Ueki N, Sobue K, Kanda K, Hada T, Higashino K. Expression of high and low molecular weight caldesmon during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA84:9049-9053, 1987
35.
35. Yaziji H, Gown AM, Sneige N. Detection of stromal invasion in breast cancer: The myoepithelial markers. Adv Anat Pathol7:100-109, 2000
36.
36. Dardick I, Stratis M, Parks WR, De Nardi FG, Kahn, HJ. S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors. Am J Pathol138:619-628, 1991
37.
37. Hungermann D, Roeser K, Buerger H, Jakel T, Loning T, Herbst H. Relative paucity of gross genetic alterations in myoepitheliomas and myoepithelial carcinomas of salivary glands. J Pathol198:487-494, 2002
